Infectious Disease In Vitro Diagnostics Global Market Report 2025

Description

Infectious disease in vitro diagnostics are laboratory tests performed on samples such as blood, urine, or swabs to detect, identify, and monitor infectious pathogens including bacteria, viruses, fungi, and parasites. These diagnostics enable accurate and timely diagnosis, guide treatment decisions, and support disease surveillance and infection control.

The main product types in infectious disease in vitro diagnostics are instruments, reagents, and software and services. Instruments are tools or devices used to measure and monitor environmental conditions including air, water, soil, and noise. They utilize technologies such as molecular diagnostics, immunoassay, microbiology, hematology, urinalysis, and others. Applications include methicillin-resistant Staphylococcus aureus, Clostridium difficile, respiratory viruses, tuberculosis and drug-resistant tuberculosis, gonorrhea, human papillomavirus, human immunodeficiency virus, hepatitis C, hepatitis B, and more. End-users include hospitals, clinics, diagnostic laboratories, academic research institutes, and other organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The infectious disease in vitro diagnostics market research report is one of a series of new reports from The Business Research Company that provides infectious disease in vitro diagnostics market statistics, including infectious disease in vitro diagnostics industry global market size, regional shares, competitors with an infectious disease in vitro diagnostics market share, detailed infectious disease in vitro diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the infectious disease in vitro diagnostics industry. This infectious disease in vitro diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infectious disease in vitro diagnostics market size has grown strongly in recent years. It will grow from $14.14 billion in 2024 to $15.1 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period is attributed to antibiotic resistance, globalization and travel, an aging population, the emergence of novel pathogens, and bioterrorism threats.

The infectious disease in vitro diagnostics market size is expected to see strong growth in the next few years. It will grow to $19.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing demand for point-of-care testing, rising prevalence of infectious diseases, growing adoption of personalized medicine, and expansion of healthcare infrastructure in emerging markets. Key trends in the forecast period include next-generation sequencing, microfluidics-based platforms, lab-on-a-chip technology, multiplex polymerase chain reaction (PCR) assays, and digital immunoassays.

The rise in global infectious diseases drove the growth of the infectious disease in vitro diagnostics market during the historic period. Infectious diseases encompass bacterial, viral, fungal, or parasitic infections affecting populations worldwide at a given time, reflecting the overall disease burden. Changes in climate have expanded the habitats of vectors such as mosquitoes, increasing the global prevalence of infectious diseases. Infectious disease in vitro diagnostics support this trend by offering precise and timely diagnostic tools that allow healthcare providers to detect pathogens, initiate appropriate treatment, and control outbreaks efficiently. For example, in October 2024, the World Health Organization reported that approximately 10.8 million people worldwide contracted tuberculosis, with 55 percent men, 33 percent women, 12 percent children and adolescents, and 6.1 percent of cases among individuals living with HIV. Therefore, the rising global prevalence of infectious diseases contributed to the growth of the infectious disease in vitro diagnostics market during the historic period.

Major companies in the infectious disease in vitro diagnostics market are developing innovative products such as rapid detection of multiple gastrointestinal pathogens to enable timely diagnosis, improve patient outcomes, and expand point-of-care testing. Rapid detection of multiple gastrointestinal pathogens involves diagnostic tests that quickly identify several disease-causing microorganisms in the gastrointestinal tract from a single sample. In June 2024, MP Biomedicals, a US-based provider of products, chemicals, and diagnostics, launched immunochromatographic rapid diagnostic kits for gastrointestinal infectious diseases. These kits allow fast and accurate detection of Helicobacter pylori, Salmonella typhi, and Vibrio cholerae serogroups O1 and O139. They support rapid, point-of-care qualitative detection, versatile sample use including stool, blood, plasma, serum, water, and food, and are suitable for both clinical and research settings. Using immunochromatographic technology, they support early diagnosis, treatment monitoring, and confirmation of pathogen eradication, offering a combination of speed, precision, and broad pathogen coverage.

In January 2025, Fremman Capital, a UK-based private equity firm focused on healthcare and life sciences investments, acquired a majority stake in DIESSE Diagnostica Senese for an undisclosed sum. Fremman Capital intends to accelerate DIESSE's international growth and reinforce its position in the specialty in vitro diagnostics market by supporting innovation, expanding the product range for autoimmune and infectious disease diagnostics, and increasing production capacity at DIESSE's biotech campus, driving long-term sustainable growth. DIESSE Diagnostica Senese is an Italy-based developer of innovative in vitro diagnostics and reagents for autoimmunity, infectious diseases, and hematological testing, serving clinical laboratories worldwide.

Major companies operating in the infectious disease in vitro diagnostics market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, BioMerieux SA, Qiagen N.V., Becton, Dickinson and Company, Hologic, Inc., Labcorp Holdings Inc., DiaSorin S.p.A., Meridian Bioscience, Quidel Corporation, Quest Diagnostics, Revvity Inc. (Formerly PerkinElmer, Inc.), OraSure Technologies, Inc., Transasia Bio-Medicals Ltd., Randox Laboratories, Luminex Corporation, Wako Pure Chemical Industries, Bio-Rad Laboratories Inc., Trivitron Healthcare, and InBios International Inc.

North America was the largest region in the infectious disease in vitro diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease in vitro diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infectious disease in vitro diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infectious disease in vitro diagnostics market consists of revenues earned by entities by providing services such as serology testing, rapid diagnostic testing, disease surveillance and monitoring, sample collection and processing, and consulting and training services. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease in vitro diagnostics market also includes sales of rapid test kits, culture media, controls and calibrators, molecular sequencing kits, flow cytometry reagents, and point-of-care diagnostic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infectious Disease In Vitro Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infectious disease in vitro diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for infectious disease in vitro diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infectious disease in vitro diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Instruments; Reagents; Software And Services
2) By Technology: Molecular Diagnostics; Immunoassay; Microbiology; Hematology; Urinalysis; Other Technologies
3) By Application: Methicillin-Resistant Staphylococcus Aureus (MRSA); Clostridium Difficile; Respiratory Virus; Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB); Gonorrhea; Human Papillomavirus (HPV); Human Immunodeficiency Virus (HIV); Hepatitis C; Hepatitis B; Other Applications
4) By End-Use: Hospitals And Clinics; Diagnostic Laboratories; Academic Research Institutes; Other End-Users
Subsegments:
1) By Instrument: Polymerase Chain Reaction Machines; Immunoassay Analyzers; Microbiology Analyzers; Hematology Analyzers; Urinalysis Analyzers; Next Generation Sequencers; Flow Cytometers
2) By Reagent: Molecular Reagents; Immunoassay Reagents; Microbiology Reagents; Hematology Reagents; Urinalysis Reagents; Enzymes And Buffers; Controls And Calibrators
3) By Software And Services: Data Management Software; Laboratory Information Systems; Cloud Based Solutions; Maintenance And Support Services; Consulting And Training Services; Remote Monitoring Services
Companies Mentioned: F. Hoffmann-La Roche AG; Abbott Laboratories; Danaher Corporation; Thermo Fisher Scientific Inc.; Siemens Healthcare AG; BioMerieux SA; Qiagen N.V.; Becton; Dickinson and Company; Hologic; Inc.; Labcorp Holdings Inc.; DiaSorin S.p.A.; Meridian Bioscience; Quidel Corporation; Quest Diagnostics; Revvity Inc. (Formerly PerkinElmer; Inc.); OraSure Technologies; Inc.; Transasia Bio-Medicals Ltd.; Randox Laboratories; Luminex Corporation; Wako Pure Chemical Industries; Bio-Rad Laboratories Inc.; Trivitron Healthcare; and InBios International Inc.
Countries:

Product Code: r40035

1. Executive Summary

2. Infectious Disease In Vitro Diagnostics Market Characteristics

3. Infectious Disease In Vitro Diagnostics Market Trends And Strategies

4. Infectious Disease In Vitro Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Infectious Disease In Vitro Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Infectious Disease In Vitro Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Infectious Disease In Vitro Diagnostics Market Growth Rate Analysis
5.4. Global Infectious Disease In Vitro Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Infectious Disease In Vitro Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Infectious Disease In Vitro Diagnostics Total Addressable Market (TAM)

6. Infectious Disease In Vitro Diagnostics Market Segmentation

6.1. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Instruments
Reagents
Software And Services
6.2. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Molecular Diagnostics
Immunoassay
Microbiology
Hematology
Urinalysis
Other Technologies
6.3. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Clostridium Difficile
Respiratory Virus
Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB)
Gonorrhea
Human Papillomavirus (HPV)
Human Immunodeficiency Virus (HIV)
Hepatitis C
Hepatitis B
Other Applications
6.4. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Laboratories
Academic Research Institutes
Other End-Users
6.5. Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction Machines
Immunoassay Analyzers
Microbiology Analyzers
Hematology Analyzers
Urinalysis Analyzers
Next Generation Sequencers
Flow Cytometers
6.6. Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Reagent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Molecular Reagents
Immunoassay Reagents
Microbiology Reagents
Hematology Reagents
Urinalysis Reagents
Enzymes And Buffers
Controls And Calibrators
6.7. Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Management Software
Laboratory Information Systems
Cloud Based Solutions
Maintenance And Support Services
Consulting And Training Services
Remote Monitoring Services

7. Infectious Disease In Vitro Diagnostics Market Regional And Country Analysis

7.1. Global Infectious Disease In Vitro Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Infectious Disease In Vitro Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Infectious Disease In Vitro Diagnostics Market

8.1. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Infectious Disease In Vitro Diagnostics Market

9.1. China Infectious Disease In Vitro Diagnostics Market Overview
9.2. China Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Infectious Disease In Vitro Diagnostics Market

10.1. India Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Infectious Disease In Vitro Diagnostics Market

11.1. Japan Infectious Disease In Vitro Diagnostics Market Overview
11.2. Japan Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Infectious Disease In Vitro Diagnostics Market

12.1. Australia Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Infectious Disease In Vitro Diagnostics Market

13.1. Indonesia Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Infectious Disease In Vitro Diagnostics Market

14.1. South Korea Infectious Disease In Vitro Diagnostics Market Overview
14.2. South Korea Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Infectious Disease In Vitro Diagnostics Market

15.1. Western Europe Infectious Disease In Vitro Diagnostics Market Overview
15.2. Western Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Infectious Disease In Vitro Diagnostics Market

16.1. UK Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Infectious Disease In Vitro Diagnostics Market

17.1. Germany Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Infectious Disease In Vitro Diagnostics Market

18.1. France Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Infectious Disease In Vitro Diagnostics Market

19.1. Italy Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Infectious Disease In Vitro Diagnostics Market

20.1. Spain Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Infectious Disease In Vitro Diagnostics Market

21.1. Eastern Europe Infectious Disease In Vitro Diagnostics Market Overview
21.2. Eastern Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Infectious Disease In Vitro Diagnostics Market

22.1. Russia Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Infectious Disease In Vitro Diagnostics Market

23.1. North America Infectious Disease In Vitro Diagnostics Market Overview
23.2. North America Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Infectious Disease In Vitro Diagnostics Market

24.1. USA Infectious Disease In Vitro Diagnostics Market Overview
24.2. USA Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Infectious Disease In Vitro Diagnostics Market

25.1. Canada Infectious Disease In Vitro Diagnostics Market Overview
25.2. Canada Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Infectious Disease In Vitro Diagnostics Market

26.1. South America Infectious Disease In Vitro Diagnostics Market Overview
26.2. South America Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Infectious Disease In Vitro Diagnostics Market

27.1. Brazil Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Infectious Disease In Vitro Diagnostics Market

28.1. Middle East Infectious Disease In Vitro Diagnostics Market Overview
28.2. Middle East Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Infectious Disease In Vitro Diagnostics Market

29.1. Africa Infectious Disease In Vitro Diagnostics Market Overview
29.2. Africa Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Infectious Disease In Vitro Diagnostics Market Competitive Landscape And Company Profiles

30.1. Infectious Disease In Vitro Diagnostics Market Competitive Landscape
30.2. Infectious Disease In Vitro Diagnostics Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Siemens Healthcare AG Overview, Products and Services, Strategy and Financial Analysis

31. Infectious Disease In Vitro Diagnostics Market Other Major And Innovative Companies

31.1. BioMerieux SA
31.2. Qiagen N.V.
31.3. Becton
31.4. Dickinson and Company
31.5. Hologic Inc.
31.6. Labcorp Holdings Inc.
31.7. DiaSorin S.p.A.
31.8. Meridian Bioscience
31.9. Quidel Corporation
31.10. Quest Diagnostics
31.11. Revvity Inc. (Formerly PerkinElmer Inc.)
31.12. OraSure Technologies Inc.
31.13. Transasia Bio-Medicals Ltd.
31.14. Randox Laboratories
31.15. Luminex Corporation

32. Global Infectious Disease In Vitro Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infectious Disease In Vitro Diagnostics Market

34. Recent Developments In The Infectious Disease In Vitro Diagnostics Market

35. Infectious Disease In Vitro Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Infectious Disease In Vitro Diagnostics Market In 2029 - Countries Offering Most New Opportunities
35.2 Infectious Disease In Vitro Diagnostics Market In 2029 - Segments Offering Most New Opportunities
35.3 Infectious Disease In Vitro Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer